<DOC>
	<DOCNO>NCT01615068</DOCNO>
	<brief_summary>This multi-center , prospective observational study evaluate treatment pattern , safety patient HER2-positive ( HER2+ ) metastatic breast cancer ( MBC ) . Eligible patient initial metastatic breast cancer diagnosis previously treat systemic therapy ; patient may enrol 6 month diagnosis . Data collect 8 year .</brief_summary>
	<brief_title>An Observational Study Patients With HER2 Positive Metastatic Breast Cancer ( SystHERs Registry )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Adult patient , &gt; /=18 year age Initial diagnosis HER2+ MBC , diagnose treat physician , 6 month prior study enrollment Availability cancerspecific historical data point patient 's medical record Any inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>